Clinical Effects and Antivenom Dosing in Brown Snake (Pseudonaja spp.) Envenoming - Australian Snakebite Project (ASP-14)

被引:68
作者
Allen, George E. [2 ]
Brown, Simon G. A. [3 ,4 ]
Buckley, Nicholas A. [1 ,5 ]
O'Leary, Margaret A. [6 ,7 ]
Page, Colin B. [1 ,7 ,8 ]
Currie, Bart J. [9 ,10 ]
White, Julian [11 ]
Isbister, Geoffrey K. [1 ,6 ,7 ]
机构
[1] Sydney Childrens Hosp Network, NSW Poisons Informat Ctr, Sydney, NSW, Australia
[2] Queen Elizabeth II Jubilee Hosp, Emergency Dept, Brisbane, Qld, Australia
[3] Royal Perth Hosp, Western Australian Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA, Australia
[4] Univ Western Australia, Perth, WA 6009, Australia
[5] Univ New S Wales, Sch Med, Prince Wales Hosp, Med Professorial Unit, Sydney, NSW, Australia
[6] Univ Newcastle, Discipline Clin Pharmacol, Newcastle, NSW 2300, Australia
[7] Calvary Mater Newcastle, Dept Clin Toxicol & Pharmacol, Newcastle, NSW, Australia
[8] Princess Alexandra Hosp, Emergency Dept, Brisbane, Qld 4102, Australia
[9] Menzies Sch Hlth Res, Darwin, NT, Australia
[10] No Terr Clin Sch, Darwin, NT, Australia
[11] Womens & Childrens Hosp, Dept Toxinol, Adelaide, SA, Australia
来源
PLOS ONE | 2012年 / 7卷 / 12期
基金
澳大利亚国家健康与医学研究理事会;
关键词
IN-VITRO; VENOM; EFFICACY; TEXTILIS; COAGULOPATHY; ANAPHYLAXIS; DEATHS; BITE;
D O I
10.1371/journal.pone.0053188
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Snakebite is a global health issue and treatment with antivenom continues to be problematic. Brown snakes (genus Pseudonaja) are the most medically important group of Australian snakes and there is controversy over the dose of brown snake antivenom. We aimed to investigate the clinical and laboratory features of definite brown snake (Pseudonaja spp.) envenoming, and determine the dose of antivenom required. Methods and Finding: This was a prospective observational study of definite brown snake envenoming from the Australian Snakebite Project (ASP) based on snake identification or specific enzyme immunoassay for Pseudonaja venom. From January 2004 to January 2012 there were 149 definite brown snake bites [median age 42y (2-81y); 100 males]. Systemic envenoming occurred in 136 (88%) cases. All envenomed patients developed venom induced consumption coagulopathy (VICC), with complete VICC in 109 (80%) and partial VICC in 27 (20%). Systemic symptoms occurred in 61 (45%) and mild neurotoxicity in 2 (1%). Myotoxicity did not occur. Severe envenoming occurred in 51 patients (38%) and was characterised by collapse or hypotension (37), thrombotic microangiopathy (15), major haemorrhage (5), cardiac arrest (7) and death (6). The median peak venom concentration in 118 envenomed patients was 1.6 ng/mL (Range: 0.15-210 ng/mL). The median initial antivenom dose was 2 vials (Range: 1-40) in 128 patients receiving antivenom. There was no difference in INR recovery or clinical outcome between patients receiving one or more than one vial of antivenom. Free venom was not detected in 112/115 patients post-antivenom with only low concentrations (0.4 to 0.9 ng/ml) in three patients. Conclusions: Envenoming by brown snakes causes VICC and over a third of patients had serious complications including major haemorrhage, collapse and microangiopathy. The results of this study support accumulating evidence that giving more than one vial of antivenom is unnecessary in brown snake envenoming.
引用
收藏
页数:9
相关论文
共 32 条
  • [1] Solving the 'Brown snake paradox': In vitro characterisation of Australasian snake presynaptic neurotoxin activity
    Barber, Carmel M.
    Isbister, Geoffrey K.
    Hodgson, Wayne C.
    [J]. TOXICOLOGY LETTERS, 2012, 210 (03) : 318 - 323
  • [2] Molecular diversity in venom from the Australian Brown snake, Pseudonaja textilis
    Birrell, GW
    Earl, S
    Masci, PP
    de Jersey, J
    Wallis, TP
    Gorman, JJ
    Lavin, MF
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (02) : 379 - 389
  • [3] Clinical features and severity grading of anaphylaxis
    Brown, SGA
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (02) : 371 - 376
  • [4] Chaisakul J, 2012, TOXICOL LETT
  • [5] Currie B.J, 2000, EMERGEN MED, V12, P285
  • [6] Snakebite in tropical Australia: a prospective study in the "Top End" of the Northern Territory
    Currie, BJ
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (11-12) : 693 - 697
  • [7] Envenoming by the rough-scaled snake (Tropidechis carinatus): a series of confirmed cases
    Gan, Melissa
    O'Leary, Margaret A.
    Brown, Simon G. A.
    Jacoby, Tamara
    Spain, David
    Tankel, Alan
    Gavaghan, Chris
    Garrett, Peter
    Isbister, Geoffrey K.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2009, 191 (03) : 183 - 186
  • [8] Health, 2007, SNAK SPID CLIN MAN G
  • [9] FATAL BROWN SNAKE (PSEUDONAJA-TEXTILIS) ENVENOMATION DESPITE THE USE OF ANTIVENOM
    HENDERSON, A
    BALDWIN, LN
    MAY, C
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1993, 158 (10) : 709 - 710
  • [10] Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12)
    Isbister, G. K.
    White, J.
    Currie, B. J.
    O'Leary, M. A.
    Brown, S. G. A.
    [J]. TOXICON, 2011, 58 (08) : 634 - 640